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a b s t r a c t
The SLIT glycoproteins and their roundabout (ROBO) receptors were originally identified
as axon guidance molecules that prevent axons from re-crossing the midline. In addition,
the SLIT–ROBO interaction is involved in the regulation of cell migration, cell death and
angiogenesis. Furthermore, it has a pivotal role during the morphogenesis, controlling
the correct development of lung, kidney, liver and breast. The functions which the SLIT–
ROBO fulfills during tissue morphogenesis are often dysregulated during cancer develop-
ment. Therefore inactivation of certain SLITs and ROBOs is associated with advanced
tumor formation and progression in disparate tissues. However, some studies revealed
that SLIT–ROBO may promote tumor angiogenesis and, consequently, its growth. This
review is focused on summarizing the current knowledge about the role of SLIT–ROBO
pathway in development of disparate tissues in physiological conditions and in pathoge-
nesis of neoplasms, including hematological malignancies.
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SLIT and their ROBO receptors are members of the axon
guidance molecules family that have been identified to play
a crucial role in development of nervous system of verte-
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preventing axons from migrating to inappropriate locations.
As the vascular and axon network shows many similarities
in their structure (reviewed by Carmeliet and Tessier-
Lavigne, 2005) [1], researchers started to investigate whether
there exist similar signaling pathways, too. As a result, in
last 20 years, the axon guidance cues have widely been 2, 93-510 Łódź, Poland. Tel.: +48 426 8951 91;
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Table I – Neuronal guidance molecules and their recep-
tors
Tabela I – Neuronalne czynniki przewodzenia i ich receptory
Ligand Receptor
Semaphorins: Class 3/class 4–7 Neuropilins
Integrins
Plexin – B/C/D
Ephrins A/B EphA/B Receptors
Netrin 1/2/4 DCC, UNC5A-D
Delta-like (Dll-1/3/4) Notch 1/2/3/4
Serrate-like (JAG1, JAG2) Notch 1/2/3/4
Slit 1/2/3/ Robo 1/2/3/4
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downsignalling, influencing apoptosis, cell cycle, cell migra-
tion determines its multiple roles in organogenesis and
tumorigenesis. There is evidence that SLIT–ROBO signaling
may take part in the pathogenesis of hematological malig-
nancies. The aim of this article is to present the current
knowledge about the role of SLIT–ROBO pathway in develop-
ment of disparate tissues in both, physiological and patho-
logical conditions.
SLIT–ROBO structure and signaling
SLIT is a secreted protein that was first described as a ligand
for ROBO in 1999, by Brose et al. [2]. Invertebrates have
single slit protein whereas vertebrates have three of them
named slit1, slit2, and slit3. All slits remain evolutionarily
conserved. It concerns their structure as well as function [2].
The slit is a glycoprotein of about 200 kDa that consists of
an N-terminal signal peptide, four leucine-rich domains
(LRR) termed D1–D4 followed by seven to nine endothelial
growth factor-like domains (EGF-like), a laminin-G domain,
and a C-terminal cystein knot (Fig. 1) [3]. Structural studies
have shown that the LRR domains each contain a motif that
creates a concave shape that might be important for Slit
interaction with their receptors. Slits are proteolytically
cleaved between two EGF-like domains [2].
As well as slit, robo was first discovered in Drosophila
melanogaster [4]. There had been three homolog proteins
described, robo1, robo2, and robo3. Subsequently, another
protein, robo4 (also termed as magic roundabout), was
identified in vertebrates and was initially thought to be
endothelial specific [5]. Robo1, robo2 and robo3 share the
same extracellular domain structure. This region contains
five immunoglobulins-like (Ig) domains and three fibronec-
tin type 3 (FN3) repeats [4]. The intracellular part of robo1–
robo3 is comprised of four conserved cytoplasmic motifs
(CC0, CC1, CC2, CC3). ROBO 3 lacks of CC1 domain [4]. Robo4,
which shows the lowest homology with other Robos, con-
tains only two Ig domains, a FN3 and CC2 domain [5]
(Fig. 1). The D2 domain of the slit and Ig2 domain of robo
are crucial for ligand–receptor interaction [6]. The slit–robo
interaction leads to the actin cytoskeleton reorganization in
the target cells. Slit binding to robo is involved in a great
amount of cell functions, mainly concerning cytoskeletal
dynamics and cell cycle (Fig. 2) [3]. To direct the motility of
cells, slit–robo requires several adaptor proteins whichconduct the signal to the effector proteins that subsequently
can change the structure of cytoskeleton. The Rac family of
small GTPases (srGAP – Slit Robo Rho GTPase activating
protein) are crucial for the downstream signaling of SLIT–
ROBO [7]. The most established function of slit–robo is its
pro- or anti-migratory activity. Slit–robo can stimulate the
interaction between E-cadherin and b-catenin and so pro-
motes cell adhesion [8]. This was observed during mammary
gland development [9]. Nevertheless, during the heart mor-
phogenesis, slit–robo inhibits the E-cadherin/b-catenin-
mediated cell to cell adhesion. This allows to form the heart
lumen [10]. As well as migration and adhesion, slit–robo can
regulate other processes involved in cell growth. Through
direct blocking of cdc42 (cell division control protein 42)
activity, the cell cycle is blocked [11]. In addition, slit and
robo control these functions independently. Slit induces
apoptosis through binding to netrin-1, which disables its
interaction with DCC (deleted in colorectal cancer). Conse-
quently, caspases 3 and 9 can be activated by DCC. What is
more, robo binds to DCC too and in turn causes dissociation
of Netrin-1 from DCC and activation of caspases [12]. Slit
inhibits cell cycle by blocking SDF-1, WNT and HGF signaling
[8]. Through the multiple pathways, SLIT–ROBO is involved
in morphogenesis, angiogenesis and tumorigenesis.
The role of SLIT–ROBO in CNS development
Robo receptors and their ligands Slit form one of the most
crucial pairings among the axon guidance molecules. robo
gene was identified in Drosophila as one that controls the
midline crossing of commissural axons [4]. Similarly, slit
was described as a protein secreted by midline glia cells
[13]. The migrating axons are chemotactically attracted to
the midline. After crossing it, is started to be expressed on
their surface. Consequently, the high concentration of slit in
midline glia cells and the expression of robo prevent
recrossing the line and so the axons find their way to the
destination place [14]. In robo/robo Drosophila embryos,
commissural axons crossed the midline multiple times [14].
Furthermore, slit–robo functions in many developmental
processes in CNS outside the midline. These include: the
formation of the olfactory tract [15], optic tract and optic
chiasm [16], and motor axon path finding in the hindbrain
[17].
The role of SLIT–ROBO in organogenesis
In addition to axon guidance function at the CNS, slits and
robos are also implicated in other developmental processes.
First data about the importance of Slit and Robo in organo-
genesis come from experiments on mutant mice [18]. Mice
with deletion of Robo1 died shortly after its birth because of
respiratory failure. Further investigations showed that these
mice had severe lung defects, such as abnormal and
torturous bronchiole [18]. Grieshammer et al. described
kidney abnormalities in Slit2 and Robo2 mutant mice which
consequently led them to quick death [19]. Similar findings
were made in Slit3 mutant mice. Besides kidney defects,
Fig. 1 – Slit and Robo structure, [3]
Ryc. 1 – Budowa Slit i Robo, [3]
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ventricle of heart were observed [20]. The slit–robo interac-
tion seems to play an important role in the development of
the heart. In Drosophila, slit in cooperation with robo1 and
robo2 directs cardioblasts migration, and through inhibition
of E-cadherin, controls their adhesion. In turn, the lumen of
the heart originates [10]. Mounting evidence confirms the
great significance of slit–robo in reproductive system. While
studying mammary gland development, Slit–Robo was con-
sidered as an adhesion molecule [21]. Dickinson et al.showed that SLIT2, SLIT3, ROBO1, ROBO2, and ROBO4 are
expressed in corpus luteum (CL) in human ovary [22].
Interestingly, the concentration rate of the cues was rising
with the duration time of luteal phase, reaching its top in
the late phase, when CL is starting to regress [22]. Con-
versely, however, when hCG (human chorionic gonadotro-
pin) is released in order to protect CL from luteolysis, the
concentration of SLIT2, SLIT3, and ROBO2 decreases rapidly
[22]. These data suggest that SLITs and ROBOs promote
luteolysis and that their expression may be regulated
Fig. 2 – SLIT–ROBO function, [3]
Ryc. 2 – Szlaki sygnałowe SLIT-ROBO, [3]
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gical development, but their activity is also known in many
pathologic circumstances. Expression of SLIT2 correlated with
increased microvascular density (MVD) in endometriosis and
was higher in recurrent endometriomas in comparison to
non-recurrent [23]. Overall, during organogenesis, the SLIT–
ROBO pathway controls numerous processes that seem to be
vital in the development of different tissues.
The SLIT–ROBO interaction in angiogenesis
Blood vessels often go alongside the nerves in the body and
the vascular and neural networks look similar in its struc-
ture. Indeed, there are several parallels in the development
of both systems (reviewed by Carmeliet and Tessier-Lavigne[1]). One of the common factors is involving in vasculogen-
esis all the members of the axon guidance molecules
including Slit and Robo. Robo4 was the first to be associated
with angiogenesis. It was discovered by data mining for
searching for new endothelial specific genes [24]. Expression
of Robo4 was detected in mouse placental blood vessels [24],
heart, liver, kidney, and lung [25]. However, there was no
expression found in the brain, skeletal muscle, spleen, and
testis [25]. Suchting et al. reported an inhibitory effect of
soluble chimeric receptor Robo4 on angiogenesis in vitro and
in vivo [26]. They also suggested that Robo4 does not bind to
any of the Slits [26]. However, the theory was not confirmed
in any of the subsequent studies.
Slit2, by activating its receptor Robo4, was reported as an
inhibitor factor for vascular-endothelial growth factor
(VEGF)-induced migration of mouse endothelial lung cells
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of several cell lines, such as human umbilical cord vascular
endothelial cell (HUVEC) [28], or human microvascular
endothelial cell (HMVEC) [29]. Besides this, SLIT2 decreased
migration of human aortic smooth muscle cells [30]. In
another study, HEK (human embryonic kidney) cells were
initially transfected with ROBO4, then placed in SLIT2-
conditioned medium. This results in inhibition of migration
of the HEK cells [25]. Similar effects were observed with
HMVEC [25]. These results implicate SLIT as an inhibitory
angiogenic factor. Nonetheless, some experiments showed
discordant conclusions. HUVEC cell lines which were treated
with medium containing SLIT2 presented directional migra-
tion [31]. The effect was blocked by treating the cells with
an antibody against ROBO1 [31]. In addition, human malig-
nant melanoma cells (A375), which normally induce angio-
genesis, produced fewer vessels when treated with an anti-
ROBO antibody [31]. Taken together, SLIT–ROBO seems to be
involved in endothelial cell migration but the discordant
results in studies confirm the complexity of the process.
Therefore, studies on the downstream signaling of the SLIT–
ROBO will be crucial to understand the differences.
SLIT–ROBO in tumor formation
The cellular functions that are controlled by the SLIT–ROBO
pathway during tissue morphogenesis are dysregulated
during cancer development. Deletions or epigenetic modifi-
cation of the slit–robo genes has recently been described in
many tumors. There is mounting evidence indicating that
SLIT 1, 2, 3, ROBO1, and 2 are candidate genes for tumor
suppressor genes. The hypermethylation of these genes was
described in numerous tumor types including cervical can-
cer, breast, non-small cell lung and ovarian [32–35]. What is
more, Singh et al. suggested poorer prognosis for patients
with cervical cancer patients in which the deletion of SLIT2
locus was confirmed [32]. A decreased expression of SLIT1, 2,
3, and ROBO 1 was reported in glioma, kidney, breast, and
lung carcinoma [36]. In addition, another study revealed
lower expression of SLIT2, 3, ROBO1, 2 and 4 in epithelial cell
ovarian carcinoma [37]. Although the findings had showed
no clear correlation with tumor clinical stage, subsequent
studies on many cancer cell lines revealed that the reex-
pression of SLIT2 greatly inhibits the proliferation of cancer
cells, which suggests the role of Slit in tumor progression
[36]. The investigation of germinal cell ovarian carcinoma
showed deletion of locus for SLIT3 [38]. In one study,
conducted by Xian et al., a targeted mutation of Robo1 gene
was generated in mice. The majority of Robo1 heterozygotes
developed neoplasms, including carcinomas and lympho-
mas [39]. Interestingly, however, these candidate genes
showed no clear trend in other tumors, being upregulated in
prostate carcinoma [40] and in many tumor cell lines, such
as melanoma, bladder squamous carcinoma, neuroblas-
toma, small cell lung carcinoma [31]. Expression of SLIT3
correlated with areas of increased microvessel density in
tumors and SLIT2-ROBO1 induced proangiogenic pathways
[31]. The activity was blocked by an antibody to the
ectodomain of ROBO–ROBO N. The ambiguous results wereobtained in some independent studies concerning SLIT–
ROBO activity in metastasis, too. Prasad et al. provided an
evidence of anti-metastatic activity of SLIT2 in breast cancer
and melanoma cells [41]. They suggested a model in which
SLIT2 inhibited the SDF-1 induced chemotaxis of T-cells (for
details, see Fig. 2) [41]. On the contrary, findings of Schmid
et al. revealed SLIT2 as a chemoattractant for breast cancer
cells that promoted brain metastases [42]. Furthermore, the
expression of SLIT2 correlated with the clinical stage of
endometrium carcinoma, being significantly higher in recur-
rent phase [43]. On the contrary, in mice bearing breast
carcinoma, the injection of exogenic Slit2 reduced the tumor
size by over a half [8]. SLIT–ROBO may induce apoptosis of
cells and the pathway is also involved in cancer biology. In
SLIT2-transfected fibrosarcomas and squamosous cell carci-
noma there was a higher number of apoptotic cells and
a lower rate of proliferation [44]. Additionally, SLIT–ROBO
induced programmed cell death through caspase-3 activa-
tion in ovarian tumor [37]. Overall, these findings indicate
that the SLIT–ROBO pathway mainly suppresses tumor
formation and growth by regulating processes including
invasion, migration, proliferation, and apoptosis. However,
more experiments are needed to explain the differences
between pro- and anti-cancerous activity of SLIT–ROBO.
SLIT–ROBO in hematological malignancies
Although the SLIT–ROBO role in solid tumors have recently
been examined extensively, the studies dedicated to hema-
tological malignancies have started few years ago and are
represented poorly. The background to research of ROBO4
expression in leukemias noticed Smith-Berdan et al. in 2011
[45]. They demonstrated the expression of the protein in
hematopoietic stem cells (HSC) and described its role in
hematopoietic niche reaching by HSC. Leukemia is believed
to derive from leukemia stem cell (LSC) and there exists
evidence that the regulation of LSC is similar to the HSC. Up
to date, only two studies concerning the role of SLIT–ROBO
in leukemias were conducted. The first determined the
methylation status of SLIT2 gene in 64 blood marrow
samples of pediatric acute lymphoblastic leukemia (ALL), 30
blood samples of adult chronic lymphocytic leukemia (CLL),
both of them obtained at the time of diagnosis, and in ten
leukemia cell lines. The study also revealed the methylation
status of the genes after treatment with a demethylating
agent. All of leukemia cell lines had completely methylated
SLIT2. Additionally, in pediatric ALL, 83% of T-ALL and 58%
of B-ALL had methylated SLIT2. However, the mutational
status of SLIT2 had no impact on clinical data in ALL.
Interestingly, SLIT2 expression was restored after treating
ALL lines with 5-aza-2dC (5-aza-2-deoxycytidine, decitabine).
80% of CLL samples demonstrated SLIT2. However, no
correlation was found between the methylation status and
IGVH or TP53 mutational status. Besides this, there was no
association between SLIT2 methylation and CLL progression
[46]. In another study, Wellbrock et al. determined mRNA
expression status of ROBO1, 4, and SLIT2 genes in quantita-
tive polymerase chain reaction (PCR) analysis in 104 patients
with newly diagnosed acute myeloid leukemia (AML). The
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mRNA was expressed in 83% patients. ROBO1 was detected
in 27% and SLIT2 in 18% of AML patients. The findings
revealed a negative correlation of high ROBO4 expression
with overall survival (OS) and event-free survival (EFS).
What is more, the complete remission (CR) rate was 54% for
the high ROBO4 expression group compared with 71% in the
low ROBO4 expression group [47]. Interestingly, for ROBO1
and SLIT2 no significant impact on survival was observed.
To conclude, these findings are promising for searching for
new prognostic factors and therapeutic aims of leukemias,
particularly in AML. Nevertheless, it requires more research
to confirm the role of SLIT–ROBO in leukemogenesis and to
determine any association with patient survival and other
pathological features.
Summary
Despite the considerable body of knowledge of the role of
SLIT–ROBO in axon guidance, neuronal migration and axon
branching, the information on the effects of SLIT–ROBO on
normal and neoplastic cells is still fragmentary. It has been
suggested that the pathway seems to regulate proliferation,
apoptosis, adhesion and angiogenesis. Recent studies
implied its key role during organ development, tumorigen-
esis and physiology. Up to date, deletions or epigenetic
modification of the SLIT–ROBO genes has been described in
many tumors which might suggest their role as a tumor
suppressor gene. However, some contradictory statements
about its role in metastasis show that the SLIT–ROBO path-
way is extremely important but highly complex. Therefore,
new studies are needed to give more details about its
activity and determine its role in tumor biology.
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